Olaisen, C.; Røst, L.M.; Sharma, A.; Søgaard, C.K.; Khong, T.; Berg, S.; Jang, M.; Nedal, A.; Spencer, A.; Bruheim, P.;
et al. Multiple Myeloma Cells with Increased Proteasomal and ER Stress Are Hypersensitive to ATX-101, an Experimental Peptide Drug Targeting PCNA. Cancers 2024, 16, 3963.
https://doi.org/10.3390/cancers16233963
AMA Style
Olaisen C, Røst LM, Sharma A, Søgaard CK, Khong T, Berg S, Jang M, Nedal A, Spencer A, Bruheim P,
et al. Multiple Myeloma Cells with Increased Proteasomal and ER Stress Are Hypersensitive to ATX-101, an Experimental Peptide Drug Targeting PCNA. Cancers. 2024; 16(23):3963.
https://doi.org/10.3390/cancers16233963
Chicago/Turabian Style
Olaisen, Camilla, Lisa Marie Røst, Animesh Sharma, Caroline Krogh Søgaard, Tiffany Khong, Sigrid Berg, Mi Jang, Aina Nedal, Andrew Spencer, Per Bruheim,
and et al. 2024. "Multiple Myeloma Cells with Increased Proteasomal and ER Stress Are Hypersensitive to ATX-101, an Experimental Peptide Drug Targeting PCNA" Cancers 16, no. 23: 3963.
https://doi.org/10.3390/cancers16233963
APA Style
Olaisen, C., Røst, L. M., Sharma, A., Søgaard, C. K., Khong, T., Berg, S., Jang, M., Nedal, A., Spencer, A., Bruheim, P., & Otterlei, M.
(2024). Multiple Myeloma Cells with Increased Proteasomal and ER Stress Are Hypersensitive to ATX-101, an Experimental Peptide Drug Targeting PCNA. Cancers, 16(23), 3963.
https://doi.org/10.3390/cancers16233963